Log in to save to my catalogue

Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegene...

Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegene...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2620224953

Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegeneration

About this item

Full title

Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegeneration

Publisher

Switzerland: Frontiers Research Foundation

Journal title

Frontiers in integrative neuroscience, 2022-01, Vol.15, p.747901

Language

English

Formats

Publication information

Publisher

Switzerland: Frontiers Research Foundation

More information

Scope and Contents

Contents

Neural mitochondrial dysfunction, neural oxidative stress, chronic neuroinflammation, toxic protein accumulation, and neural apoptosis are common causes of neurodegeneration. Elamipretide, a small mitochondrially-targeted tetrapeptide, exhibits therapeutic effects and safety in several mitochondria-related diseases. In neurodegeneration, extensive...

Alternative Titles

Full title

Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegeneration

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2620224953

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2620224953

Other Identifiers

ISSN

1662-5145

E-ISSN

1662-5145

DOI

10.3389/fnint.2021.747901

How to access this item